ClinicalTrials.Veeva

Menu

rEduction of oXygen After Cardiac arresT: a Pilot Study (EXACT)

M

Monash University

Status and phase

Completed
Phase 2

Conditions

Heart Arrest

Treatments

Drug: Oxygen

Study type

Interventional

Funder types

Other

Identifiers

NCT02499042
CF14/2953-2014001634

Details and patient eligibility

About

This Phase 2 study aims to determine the feasibility of paramedic titration of oxygen delivery in adult patients who have been resuscitated from OHCA.

Full description

This Phase 2 study aims to test whether paramedic titration of oxygen is feasible and results in an equivalent number of patients arriving at the ED with a safe oxygen level compared with the current approach of 100% oxygen.

Hypothesis: There is no difference in the proportion of OHCA patients who arrive at the emergency department with oxygen saturation greater than or equal to 90% whether they received an inspired oxygen fraction of 100% achieved by a flow rate of 10 litres per minute compared to a titrated oxygen fraction achieved by a flow rate of 2 litres per minute.

This is a Phase 2, multi-centre, prospective, randomised study to be conducted in Melbourne and Adelaide.

During cardiac arrest, the patient will receive the current standard of care with oxygen delivery (≥10L/min) by ETT/ SGA connected to bag/valve/ oxygen reservoir.

If ROSC is achieved, all the standard post resuscitation treatments will be given as per current ambulance Clinical Practice Guidelines, except for the amount of oxygen delivered.

The initial ventilation post ROSC for two minutes will be 600mL x 10L/ minute with oxygen flow rate ≥10L/min until a satisfactory pulse oximeter trace and reading is achieved.

After the eligibility criteria are met, the patients will be randomised by the opening of an opaque envelope containing a computer generated allocation to either continued oxygen >10L/min or decreased ("titrated") oxygen 2L/min with a target oxygen saturation of 90-94%.

Patients allocated to oxygen >10L minute ("standard care") will continue on this therapy to hospital.

In the 2L/min oxygen group, the oxygen flow will be changed immediately back to >10L/min if:

  • The oxygen saturation falls to <90% at any time, or
  • Recurrent cardiac arrest occurs, or
  • The pulse oximeter trace fails Following any of these events, this high-flow oxygen will continue to hospital. If a patient is extubated or has a SGA removed post randomisation because of improving conscious state, then standard care will be used (i.e. face mask with oxygen ≥10L/min).

For patients with ROSC in whom intubation is planned, ventilation with high-flow oxygen will continue during the intubation process and randomisation will be delayed until 2 minutes after the ETT is confirmed as correctly placed using ETCO2 and the pulse oximeter trace reads ≥95%.

At ED handover, the patient will receive oxygen therapy as determined by the treating emergency medicine physician.

Enrollment

59 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults (age ≥18 years)
  • Out-of-hospital cardiac arrest of presumed cardiac cause
  • Initial cardiac rhythm ventricular fibrillation/ ventricular tachycardia ("shockable")
  • Unconscious (Glasgow Coma Scale <9)
  • In cardiac arrest on ambulance arrival
  • Sustained return of spontaneous circulation (>2 minutes)
  • Pulse oximeter trace with oxygen saturation measured at ≥95% on bag/ reservoir with oxygen set at ≥10L/min
  • Patient is spontaneous breathing or ventilated using bag/valve/oxygen reservoir via endotracheal tube or SGA (i.e. laryngeal mask airway)

Exclusion criteria

  • Female who is known or suspected to be pregnant
  • Dependant on others for activities of daily living (i.e. facilitated care or nursing home residents)
  • "Not for Resuscitation" order
  • EMS witnessed arrests

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

59 participants in 2 patient groups

Oxygen reduction
Experimental group
Description:
post-ROSC oxygen reduced to 2L per minute then delivered to maintain oxygen saturation 90-94% to hospital
Treatment:
Drug: Oxygen
Standard Care
Active Comparator group
Description:
post-ROSC oxygen maintained ≥10L per minute to hospital
Treatment:
Drug: Oxygen

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems